Bausch Health Co. Inc. (BHC) Reports Q1 Loss of $0.55/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bausch Health Announces First-Quarter 2023 Results
May 4, 2023 7:01 AM EDTFirst-Quarter revenues of $1.94 billion, up 1% reported and 4% organic1Solid revenue growth across core products, led by Xifaxan with 7% reported growthMid- and late-stage product pipeline advancingBausch Health provides consolidated full-year guidance, and Bausch Health (excl. B+L) confirms 2023 guidance
LAVAL, QC / ACCESSWIRE / May 4, 2023 / Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its first-quarter 2023 financial... More
